Healthcare -
Biotechnology - NASDAQ - US
$ 0.2962
-0.135 %
$ 21.5 M
Market Cap
-0.4
P/E
INAB - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities INAB - IN8bio, Inc.
27 M
LAST VALUE
-9.41%
2 YEAR CAGR
26.04%
5 YEAR CAGR
0.00%
10 YEAR CAGR